AXB

71.2

-0.14%↓

BRKA.US

728,130

-0.13%↓

BRKB

485.62

-0.12%↓

JPM

288.82

+1.65%↑

V

346.33

+0.1%↑

AXB

71.2

-0.14%↓

BRKA.US

728,130

-0.13%↓

BRKB

485.62

-0.12%↓

JPM

288.82

+1.65%↑

V

346.33

+0.1%↑

AXB

71.2

-0.14%↓

BRKA.US

728,130

-0.13%↓

BRKB

485.62

-0.12%↓

JPM

288.82

+1.65%↑

V

346.33

+0.1%↑

AXB

71.2

-0.14%↓

BRKA.US

728,130

-0.13%↓

BRKB

485.62

-0.12%↓

JPM

288.82

+1.65%↑

V

346.33

+0.1%↑

AXB

71.2

-0.14%↓

BRKA.US

728,130

-0.13%↓

BRKB

485.62

-0.12%↓

JPM

288.82

+1.65%↑

V

346.33

+0.1%↑

Search

Solar Capital Ltd

Fechado

16.06 0.88

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.84

Máximo

16.18

Indicadores-chave

By Trading Economics

Rendimento

-2.7M

20M

Vendas

13M

38M

P/E

Médio do Setor

9.846

24.617

EPS

0.41

Rendimento de Dividendos

10.15

Margem de lucro

52.492

EBITDA

-2.7M

20M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+1.57% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

10.15%

4.23%

Próximos Ganhos

6 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

35M

870M

Abertura anterior

15.18

Fecho anterior

16.06

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Solar Capital Ltd Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de jun. de 2025, 23:49 UTC

Ganhos

Nike Sees Sales Decline Decelerating in 1Q as Turnaround Strategy Plays Out -- 2nd Update

26 de jun. de 2025, 22:19 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC Clears Alimentation Couche-Tard's $1.57 Billion GetGo Acquisition

26 de jun. de 2025, 21:30 UTC

Ganhos

Nike 4Q Profit, Revenue Slides as Turnaround Strategy Plays Out -- Update

26 de jun. de 2025, 21:07 UTC

Ganhos

Nike 4Q Profit, Revenue Slide as Turnaround Strategy Plays Out

26 de jun. de 2025, 23:49 UTC

Conversa de Mercado

Nikkei May Rise as Fears About Middle East Conflict Ebb -- Market Talk

26 de jun. de 2025, 23:39 UTC

Conversa de Mercado

Gold Edges Lower, Weighed by Stronger-Than-Expected U.S. Data -- Market Talk

26 de jun. de 2025, 23:34 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers: Lease Reset Provides Opportunity for Upgrades, Extensions

26 de jun. de 2025, 23:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers: 62 BWP-Owned Bunnings Sites Get Significantly Longer Leases

26 de jun. de 2025, 23:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers Will No Longer Receive Earnings From BWP Management

26 de jun. de 2025, 23:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers to Increase BWP Holding to 23.5% From 22.3%

26 de jun. de 2025, 23:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers: New BWP Units Priced at 9.2% Premium to Last Close

26 de jun. de 2025, 23:31 UTC

Aquisições, Fusões, Aquisições de Empresas

BWP to Pay A$100 Mln Cash, A$42.6 Mln in New Units

26 de jun. de 2025, 23:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers' Bunnings, BWP Trust to Extend and Vary Leases

26 de jun. de 2025, 23:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Wesfarmers to Sell BWP Management to BWP Trust for A$142.6M

26 de jun. de 2025, 23:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Andlauer Healthcare Group: Ontario Superior Court of Justice Issues Final Order Approving Sale to UPS

26 de jun. de 2025, 22:06 UTC

Ganhos

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

26 de jun. de 2025, 21:15 UTC

Ganhos

Nike 4Q Profit, Rev Slides as Turnaround Strategy Plays Out -- Update

26 de jun. de 2025, 21:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Couche-Tard: 35 Stores to Be Divested in Accordance With Regulatory Requirements >ATD.T

26 de jun. de 2025, 21:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Couche-Tard: GetGo Will Operate as Separate, Stand-Alone Business Unit, Maintain myPerks Loyalty Program >ATD.T

26 de jun. de 2025, 21:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Couche-Tard: Buyer Will be Approved by the FTC >ATD.T

26 de jun. de 2025, 21:07 UTC

Ganhos

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

26 de jun. de 2025, 21:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Couche-Tard Agreed to Sell 35 Sites, Including 34 Circle K Locations and One GetGo Property >ATD.T

26 de jun. de 2025, 21:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Couche-Tard: Transaction Is Expected to Close in the Coming Days >ATD.T

26 de jun. de 2025, 21:06 UTC

Conversa de Mercado

Bank of Mexico Seen Likely to Slow Pace of Rate Cuts -- Market Talk

26 de jun. de 2025, 21:05 UTC

Aquisições, Fusões, Aquisições de Empresas

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

26 de jun. de 2025, 21:05 UTC

Aquisições, Fusões, Aquisições de Empresas

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

26 de jun. de 2025, 20:52 UTC

Ganhos

Nike 4Q Profit, Rev Slide as Turnaround Strategy Plays Out

26 de jun. de 2025, 20:51 UTC

Ganhos

Correct: Nike 4Q Net $211M, Not $200M >NKE

26 de jun. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

26 de jun. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

Comparação entre Pares

Variação de preço

Solar Capital Ltd Previsão

Preço-alvo

By TipRanks

1.57% parte superior

Previsão para 12 meses

Média 16.21 USD  1.57%

Máximo 19 USD

Mínimo 12 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Solar Capital Ltd - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

4

Comprar

1

Manter

2

Vender

Pontuação Técnica

By Trading Central

15.575 / 15.68Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Solar Capital Ltd

SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, healt